Takeda Exec On Access Strategies To Fit Local Contexts, Trial Inclusivity

Takeda’s president, growth and emerging markets, talks to Scrip about keeping decisions “as close to patients as possible” as the company seeks to widen access to its therapies and address gaps in health equity across the value chain including the trials arena.

Takeda is tailoring strategies to the needs of each region • Source: Shutterstock

Takeda Pharmaceutical Co. Ltd. executive Gamze Yüceland’s career path across numerous geographies has meant that she’s seen diversity of healthcare systems and challenges that impact health equity and access at close quarters.

In an interview with Scrip, Yüceland, currently Takeda’s president, growth and emerging markets (GEM), said that unequal access to healthcare...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip